Ms Rajneesh Kaur, Prof Bettina Meiser, Prof Robyn Ward, Prof Finlay Macrae Prof Janet Hiller A/Prof Judy, Dr Allison Trainer and A/Prof Gillian Mitchell.
 
eviQ point of care guidelines for cancer treatments available at https://www.eviq.org.au were developed in 2000 initially with support from Cancer Council NSW. In 2004, eviQ was transferred to the Cancer Institute NSW which to this day remains as the host site. eviQ provides accurate, current, relevant, and evidence based information for use at the point of care. All content development complies with a rigorous data governance model which is focussed on evidence-based items sourced and reviewed by clinicians who need to use this information in their daily clinical practice. This has led to clinicians viewing the resource as a key information system within the Australian context and expansion of its use beyond the NSW borders. eviQ is now established as a national platform to host point of care information for people with hereditary cancer syndromes and is of great relevance to the practice of cancer genetics.

This project consists of two components. The first part is file audit regarding compliance with eviQ guidelines as well as patient interviews to ascertain their adherence to risk reducing strategies. The second part is clinician survey of clinical staff at all Australian family cancer clinics (FCCs). The clinical staff was asked to complete two separate online surveys regarding attitudes to risk-reducing medication tamoxifen and aspirin for people at high risk for breast and or colorectal cancer (CCR) respectively.